{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:54:15Z","timestamp":1781913255425,"version":"3.54.5"},"reference-count":87,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mild bleeding disorders (MBDs) comprise a heterogeneous group of inherited conditions characterized by clinically relevant bleeding symptoms despite largely normal or inconclusive results in routine hemostatic testing. These disorders account for a substantial proportion of referrals to specialized hemostasis clinics and include von Willebrand disease (VWD), inherited platelet function disorders, and mild coagulation factor deficiencies. Despite systematic diagnostic algorithms, many patients with MBDs remain without a definitive diagnosis and are classified as having bleeding disorder of unknown cause (BDUC), complicating clinical management and counseling. Conventional diagnostic approaches rely on structured bleeding assessment tools, detailed family history, and stepwise laboratory testing. Biological variability, assay limitations, and phenotypic overlap often result in inconclusive findings.<\/jats:p>\n                  <jats:p>Recent advances in genetic analysis have begun to transform this diagnostic landscape. Targeted next-generation sequencing panels, whole-exome sequencing (WES), and whole-genome sequencing (WGS) enable identification of pathogenic variants across numerous hemostasis-related genes. In MBDs, genetic testing is valuable for refining diagnoses in qualitative VWD, confirming inherited platelet disorders, and identifying rare mild coagulopathies. In contrast, its diagnostic yield in type 1 and low von Willebrand factor (VWF) is modest, reflecting complex genetic architecture, modifier effects, and incomplete penetrance. In BDUC, genetic testing has revealed monogenic causes in some patients and multifactorial contributions in others.<\/jats:p>\n                  <jats:p>Genetic testing should therefore be regarded as a complementary tool rather than a replacing conventional diagnostics. Integrated with clinical and laboratory findings and supported by expert variant interpretation, it can reduce diagnostic uncertainty and improve disease classification in patients with MBDs.<\/jats:p>","DOI":"10.1055\/a-2887-8141","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:31:23Z","timestamp":1781911883000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond Conventional Hemostasis Testing: The Diagnostic Impact of Genetic Analysis in inherited Mild Bleeding Disorders"],"prefix":"10.1055","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-3424","authenticated-orcid":false,"given":"Behnaz","family":"Pezeshkpoor","sequence":"additional","affiliation":[{"name":"University of Bonn, NRW, Germany","place":["Bonn"],"department":["Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pavlova","sequence":"additional","affiliation":[{"name":"University of Bonn, NRW, Germany","place":["Bonn"],"department":["Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000286","article-title":"Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report","volume":"3","author":"F Rodeghiero","year":"2019","journal-title":"Hema"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.jtha.2024.03.005","article-title":"Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH","volume":"22","author":"R I Baker","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/a-2263-5706","article-title":"Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion","volume":"44","author":"D Mehic","year":"2024","journal-title":"Hamostaseologie"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/jth.14363","article-title":"Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research","volume":"17","author":"D Mezzano","year":"2019","journal-title":"J Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1182\/blood.2020010038","article-title":"How I treat bleeding disorder of unknown cause","volume":"138","author":"R I Baker","year":"2021","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102242","article-title":"Investigating patients for bleeding disorders when most of the \u201cusual\u201d ones have been ruled out","volume":"7","author":"D Mehic","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1182\/asheducation-2012.1.466","article-title":"Is my patient a bleeder? A diagnostic framework for mild bleeding disorders","volume":"2012","author":"T Quiroga","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1055\/a-1726-4793","article-title":"Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders","volume":"42","author":"B Pezeshkpoor","year":"2022","journal-title":"Hamostaseologie"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bvth.2025.100090","article-title":"How genetic advances are being translated into improved diagnostic outcomes for patients with inherited bleeding disorders","volume":"2","author":"M Chaigneau","year":"2025","journal-title":"Blood Vessel Thromb Hemost"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1182\/hematology.2025000695","article-title":"Diagnosis of bleeding disorder of unknown cause: how many tests are enough to diagnose BDUC?","volume":"2025","author":"M N Avgeropoulos","year":"2025","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"F Rodeghiero","year":"2010","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/hae.13089","article-title":"Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study","volume":"22","author":"P D James","year":"2016","journal-title":"Haemophilia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1111\/hae.12747","article-title":"Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease","volume":"21","author":"M Deforest","year":"2015","journal-title":"Haemophilia"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"P D James","year":"2021","journal-title":"Blood Adv"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1538-7836.2004.00693.x","article-title":"Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients","volume":"2","author":"T Quiroga","year":"2004","journal-title":"J Thromb Haemost"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.hoc.2021.07.001","article-title":"Approach to the Patient with Bleeding","volume":"35","author":"M Chaigneau","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.jtha.2024.05.027","article-title":"Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor","volume":"22","author":"C Kelly","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood-2018-06-820738","article-title":"Treatment of rare factor deficiencies other than hemophilia","volume":"133","author":"M Menegatti","year":"2019","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/hae.13922","article-title":"Diagnostic work up of patients with increased bleeding tendency","volume":"26","author":"S AM Zegers","year":"2020","journal-title":"Haemophilia"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jtha.2023.09.010","article-title":"The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders","volume":"22","author":"D Mehic","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1111\/jth.15871","article-title":"Outcomes and management of pregnancy in women with bleeding disorder of unknown cause","volume":"20","author":"D Castle","year":"2022","journal-title":"J Thromb Haemost"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/jth.15116","article-title":"Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease","volume":"19","author":"E Biguzzi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e908","DOI":"10.1016\/S2352-3026(25)00262-5","article-title":"Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications","volume":"12","author":"O Seidizadeh","year":"2025","journal-title":"Lancet Haematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102305","article-title":"Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC","volume":"8","author":"P Gresele","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/jth.12792","article-title":"Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH","volume":"13","author":"P Gresele","year":"2015","journal-title":"J Thromb Haemost"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1182\/blood-2018-10-844936","article-title":"How I treat low von Willebrand factor levels","volume":"133","author":"M Lavin","year":"2019","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1182\/bloodadvances.2018017418","article-title":"Significant gynecological bleeding in women with low von Willebrand factor levels","volume":"2","author":"M Lavin","year":"2018","journal-title":"Blood Adv"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1182\/bloodadvances.2020002038","article-title":"Low VWF: insights into pathogenesis, diagnosis, and clinical management","volume":"4","author":"J S O'Donnell","year":"2020","journal-title":"Blood Adv"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ijlh.14266","article-title":"How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause","volume":"46","author":"A Casini","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102625","article-title":"Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives","volume":"8","author":"A LL Monard","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1055\/a-1945-9429","article-title":"Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice","volume":"42","author":"B Pezeshkpoor","year":"2022","journal-title":"Hamostaseologie"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1055\/s-0041-1722865","article-title":"Genomic Analysis for the Detection of Bleeding and Thrombotic Disorders","volume":"47","author":"K Gomez","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm10020347","article-title":"Familial Multiple Coagulation Factor Deficiencies (FMCFDs) in a Large Cohort of Patients-A Single-Center Experience in Genetic Diagnosis","author":"B Preisler","year":"2021","journal-title":"J Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/hae.15147","article-title":"Modulation of Haemostatic Balance in Combined von Willebrand Disease and Antithrombin Deficiency: A Comprehensive Family Study","volume":"31","author":"B Pezeshkpoor","year":"2025","journal-title":"Haemophilia"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2026.02.014","article-title":"Prothrombotic PROC variant rebalancing haemostasis in severe haemophilia A with attenuated bleeding risk","author":"R Ramanan","year":"2026","journal-title":"J Thromb Haemost"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"A C Goodeve","year":"2010","journal-title":"Blood Rev"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3324\/haematol.2024.286014","article-title":"Molecular genetic testing in von Willebrand disease: past, present, and beyond","volume":"111","author":"O Seidizadeh","year":"2026","journal-title":"Haematologica"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/a-2616-5161","article-title":"Landscape and Spectrum of VWF Variants in Type 2 Von Willebrand Disease: Insights from a German Patient Cohort","volume":"126","author":"H Yadegari","year":"2026","journal-title":"Thromb Haemost"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2025.103233","article-title":"Deep molecular modeling and mechanistic insights into type 2A von Willebrand disease with von Willebrand factor A2 domain mutations","volume":"9","author":"O Seidizadeh","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3324\/haematol.2025.288342","article-title":"Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype","volume":"111","author":"O Seidizadeh","year":"2026","journal-title":"Haematologica"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.jtha.2024.05.006","article-title":"Application of genetic testing for the diagnosis of von Willebrand disease","volume":"22","author":"O Seidizadeh","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/hae.70192","article-title":"Advances in Von Willebrand Disease","author":"R Lassila","year":"2025","journal-title":"Haemophilia"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1016\/j.jtha.2024.06.026","article-title":"Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study","volume":"22","author":"A Krahforst","year":"2024","journal-title":"J Thromb Haemost"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"J E Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1182\/asheducation-2009.1.106","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease","author":"J E Sadler","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"S E Ward","year":"2020","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1182\/blood.2020009999","article-title":"von Willebrand factor antigen levels are associated with burden of rare nonsynonymous variants in the VWF gene","volume":"137","author":"B Sadler","year":"2021","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MOH.0000000000000524","article-title":"The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease","volume":"26","author":"V H Flood","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2025.102730","article-title":"Clinical utility of panel-based genetic sequencing for von Willebrand disease","volume":"9","author":"R Ramanan","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","article-title":"Whole-genome sequencing of patients with rare diseases in a national health system","volume":"583","author":"E Turro","year":"2020","journal-title":"Nature"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1182\/blood.2018891192","article-title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","volume":"134","author":"K Downes","year":"2019","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2015-12-688267","article-title":"A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders","volume":"127","author":"I Simeoni","year":"2016","journal-title":"Blood"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2025.102682","article-title":"Global prevalence of platelet-type von Willebrand disease","volume":"9","author":"O Seidizadeh","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1055\/s-0031-1281030","article-title":"Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder","volume":"37","author":"M Othman","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5482\/HAMO-13-04-0024","article-title":"Diagnose angeborener St\u00f6rungen der Thrombozytenfunktion. Interdisziplin\u00e4re S2K-Leitlinie der St\u00e4ndigen Kommission P\u00e4diatrie der Gesellschaft f\u00fcr Thrombose- und H\u00e4mostaseforschung e. V","volume":"34","author":"R Kn\u00f6fler","year":"2014","journal-title":"Hamostaseologie"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1055\/a-2628-5488","article-title":"\u201cDiagnose von angeborenen Thrombozytenfunktionsst\u00f6rungen - Thrombozytopathien\u201d: Aktualisierung der interdisziplin\u00e4ren S2k-Leitlinie * der St\u00e4ndigen Kommission P\u00e4diatrie der Gesellschaft f\u00fcr Thrombose- und H\u00e4mostaseforschung e. V","volume":"45","author":"J Gebetsberger","year":"2025","journal-title":"Hamostaseologie"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/a-1515-0813","article-title":"Diagnosing Inherited Platelet Disorders: Modalities and Consequences","volume":"41","author":"C Zaninetti","year":"2021","journal-title":"Hamostaseologie"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bvth.2024.100043","article-title":"Screening for gene variants causing inherited platelet disorders: are the cons always cons?","volume":"2","author":"L Bury","year":"2025","journal-title":"Blood Vessel Thromb Hemost"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/a-1987-3310","article-title":"Inherited Platelet Disorders: A Short Introduction","volume":"43","author":"B Zieger","year":"2023","journal-title":"Hamostaseologie"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1016\/j.jtha.2025.06.005","article-title":"The genetic spectrum of rare bleeding disorders","volume":"23","author":"S Mohsenian","year":"2025","journal-title":"J Thromb Haemost"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1055\/s-0033-1349221","article-title":"Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management","volume":"39","author":"F Peyvandi","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1055\/s-0044-1792033","article-title":"Laboratory and Molecular Diagnosis of Factor XI Deficiency","volume":"51","author":"S Davidson","year":"2025","journal-title":"Semin Thromb Hemost"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0029-1225764","article-title":"Factor XI Deficiency","volume":"35","author":"S Duga","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1055\/a-2654-8635","article-title":"Understanding Congenital FXI Deficiency: Genetic Diagnosis and Correlation of Variant Detection Rate to Factor XI Activity","volume":"45","author":"B Pezeshkpoor","year":"2025","journal-title":"Hamostaseologie"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173991","article-title":"The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes","volume":"12","author":"C PM Hayward","year":"2017","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/hae.12313","article-title":"The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: single-centre experience","volume":"20","author":"M Heiman","year":"2014","journal-title":"Haemophilia"},{"key":"ref67","first-page":"328","article-title":"Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage","volume":"15","author":"G C Griffin","year":"1993","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood.2025029571","article-title":"Human missense variants in F3 impair the initiation of blood coagulation","volume":"147","author":"S A Ansari","year":"2026","journal-title":"Blood"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3324\/haematol.2022.280816","article-title":"APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis","volume":"108","author":"S Stritt","year":"2023","journal-title":"Haematologica"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/hae.14049","article-title":"Diagnosis of rare bleeding disorders","volume":"27","author":"K Meijer","year":"2021","journal-title":"Haemophilia"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s10897-018-0289-6","article-title":"Interpretations of the Term \u201cActionable\u201d when Discussing Genetic Test Results: What you Mean Is Not What I Heard","volume":"28","author":"M C Gornick","year":"2019","journal-title":"J Genet Couns"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/cge.13917","article-title":"Pitfalls and challenges in genetic test interpretation: An exploration of genetic professionals experience with interpretation of results","volume":"99","author":"K E Donohue","year":"2021","journal-title":"Clin Genet"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1055\/s-0039-1688446","article-title":"Next-Generation Sequencing and Emerging Technologies","volume":"45","author":"K R Kumar","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"F Sanger","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/hae.13638","article-title":"Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis","volume":"25","author":"J L Saes","year":"2019","journal-title":"Haemophilia"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/bjh.14863","article-title":"Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the \u00d6resund Region","volume":"179","author":"E Lein\u00f8e","year":"2017","journal-title":"Scand Br J Haematol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/jpm13081236","article-title":"Human Exome Sequencing and Prospects for Predictive Medicine: Analysis of International Data and Own Experience","author":"O S Glotov","year":"2023","journal-title":"J Pers Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1055\/a-2806-3835","article-title":"Unveiling the Genetic Landscape of Inherited Primary Hemostasis Disorders by Whole-Exome Sequencing: Insights from a Multicenter Study","author":"P Bandini","year":"2026","journal-title":"Thromb Haemost"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2017.03.005","article-title":"Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research","volume":"169","author":"T A Manolio","year":"2017","journal-title":"Cell"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5482\/HAMO-14-11-0056","article-title":"A whole genome approach to platelet and bleeding disorders","volume":"36","author":"M Laffan","year":"2016","journal-title":"Hamostaseologie"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.920390","article-title":"Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts","volume":"13","author":"R Kingdom","year":"2022","journal-title":"Front Genet"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/jth.13368","article-title":"A diagnostic approach to mild bleeding disorders","volume":"14","author":"J Boender","year":"2016","journal-title":"J Thromb Haemost"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/jth.15658","article-title":"Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study","volume":"20","author":"M T Pagliari","year":"2022","journal-title":"J Thromb Haemost"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3324\/haematol.2017.171132","article-title":"Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders","volume":"103","author":"J M Bastida","year":"2018","journal-title":"Haematologica"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-0044-1789596","article-title":"Inherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders","volume":"51","author":"M Al-Ghafry","year":"2025","journal-title":"Semin Thromb Hemost"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2887-8141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:31:24Z","timestamp":1781911884000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2887-8141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":87,"URL":"https:\/\/doi.org\/10.1055\/a-2887-8141","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}